Yazar "Sarıoglu, Nurhan" için listeleme
-
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): Which one may be the first option in group A COPD patients?
Turan, Muzaffer Onur; Ogan, Nalan; Bozkuş, Fulsen; Sarıoglu, Nurhan; Turan, Pakize Ayşe; Satıcı, Celal (Springer Heidelberg, 2024)IntroductionLong-acting muscarinic antagonists (LAMA) or beta-2 agonists (LABA) have been recommended for symptom control in group A COPD patients as a first-line bronchodilator treatment in GOLD guidelines. However, there ...